Entera Bio ENTX Insider Ownership

Updated Oct 5, 2026

Over the past year, ENTX insiders bought $140,882 of stock (101.5K shares) on the open market and sold none.

• A count shows 5 insiders buying ENTX stock on the open market over the past 12 months and none selling.
• Among Entera Bio's insiders, the largest open-market purchases in the past 12 months were by Geno J. Germano (Director), totaling $55,800 (40K shares), most recently on March 9, 2026.
• Beyond open-market trades, insiders at Entera Bio received 896.18K shares in stock awards in the last 12 months.
• Per Business Quant data, Entera Bio insiders hold 2.42Mn shares in total based on their latest Form 4 filings, up 30.20% from 1.86Mn shares at the end of Q2 2026 and up 69.14% from 1.43Mn shares at the end of Q3 2025.
• Entera Bio insiders hold 2.23Mn shares directly (91.90% of their total) and 196.24K shares (8.10%) indirectly, through entities such as trusts and partnerships.
• Holdings in Entera Bio stock are reported by 11 insiders, the officers, directors and 10% owners who have filed a Form 4 in the past two years.
• ENTX's three largest insider shareholders, per their latest Form 4 filings, are Miranda Jayne Toledano (Chief Executive Officer, 847.13K shares), Gerald M. Lieberman (Director, 363.25K shares) and Dana Yaacov-Garbeli (Chief Financial Officer, 258.17K shares).
• The holding of Miranda Jayne Toledano makes up 34.95% of all shares held by Entera Bio insiders.
• Over the trailing 12 months, 11 insiders reported transactions in ENTX stock across 26 Form 4 filings.
• The insider holdings and trades above for Entera Bio reflect Form 4 filings through August 7, 2026.